Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium

被引:31
作者
Donner, Ludvik R. [1 ]
Wainwright, Luanne M.
Zhang, Fan
Biegel, Jadyn A.
机构
[1] Texas A&M Univ, Ctr Hlth Sci, Coll Med,Dept Pathol,Scott & White Mem Hosp & Cli, Scott Sherwood & Brindley Fdn, Temple, TX 76508 USA
[2] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA 19104 USA
关键词
INI1; gene; composite rhabdoid tumor; uterine carcinosarcoma; cyclin D1;
D O I
10.1016/j.humpath.2006.12.003
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Composite rhabdoid tumors are typically adult tumors that contain a component of rhabdoid cells, which are characteristic of the aggressive childhood malignant rhabdoid tumor. Pediatric rhabdoid tumors are characterized by the inactivation of the hSNF5/INI1/SMARCB1 gene, with subsequent loss of expression of the protein. In contrast, only a single composite rhabdoid tumor has demonstrated involvement of the INI1 gene. In our study, INI1 protein expression was studied in 2 uterine carcinosarcomas with rhabdoid components (composite rhabdoid tumors). The rhabdoid component of 1 tumor showed lack of immunoreactivity for the INI1 protein and strong positivity for cyclin D1, whereas the adenocarcinomatous component of the tumor and both components of the second tumor were immunoreactive for the INI1 protein and negative for cyclin D1. Loss of one INI1 allele and a mutation in exon 7 of the remaining allele were detected in the first tumor, consistent with the immunohistochemistry results. Our results demonstrate that deletions and mutations of the INI1 gene can occur also in rare composite rhabdoid tumors of adulthood. Further studies are necessary, however, to determine the prognostic significance of this finding. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:935 / 939
页数:5
相关论文
共 32 条
  • [1] Abbott JJ, 2004, ARCH PATHOL LAB MED, V128, P686
  • [2] Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors
    Alarcon-Vargas, D
    Zhang, Z
    Agarwal, B
    Challagulla, K
    Mani, S
    Kalpana, GV
    [J]. ONCOGENE, 2006, 25 (05) : 722 - 734
  • [3] Malignant mixed Mullerian tumor with rhabdoid features: A report of two cases and a review of the literature
    Baschinsky, DY
    Niemann, TH
    Eaton, LA
    Frankel, WL
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 73 (01) : 145 - 150
  • [4] Biegel JA, 2002, CLIN CANCER RES, V8, P3461
  • [5] Biegel JA, 1999, CANCER RES, V59, P74
  • [6] Biegel Jaclyn A, 2006, Neurosurg Focus, V20, pE11
  • [7] Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation
    Fujisawa, H
    Misaki, K
    Takabatake, Y
    Hasegawa, M
    Yamashita, J
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2005, 73 (02) : 117 - 124
  • [8] Chromosome 22q dosage in composite extrarenal rhabdoid tumors: Clonal evolution or a phenotypic mimic?
    Fuller, CE
    Pfeifer, J
    Humphrey, P
    Bruch, LA
    Dehner, LP
    Perry, A
    [J]. HUMAN PATHOLOGY, 2001, 32 (10) : 1102 - 1108
  • [9] Collision of uterine rhabdoid tumor and endometrioid adenocarcinoma: A case report and review of the literature
    Gaertner, EM
    Farley, JH
    Taylor, RR
    Silver, SA
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1999, 18 (04) : 396 - 401
  • [10] Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors
    Hoot, AC
    Russo, P
    Judkins, AR
    Perlman, EJ
    Biegel, JA
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2004, 28 (11) : 1485 - 1491